POLISCOPE
Back to bills
Part ofAbortion →

The civic record

Read. Follow. Verify.
HB 30TEXASSession 891State Billdead
Did Not Advance

Texas Bill HB 30 Bans Abortion-Inducing Drugs and Authorizes Private Qui Tam Enforcement

Original title: Relating to abortion, including civil liability for the manufacture and provision of abortion-inducing drugs, exemptions from the Texas Citizens Participation Act and Religious Freedom Restoration Act, authorizing civil and qui tam actions, amendments to the fee-shifting statute governing abortion litigation, immunity defenses and limits on state-court jurisdiction and relief, the parens patriae standing of the attorney general, and the jurisdiction of the Fifteenth Court of Appeals; providing for severability.

Last action · August 8, 2025: FiledSponsor: Jeff Leach

Companion · SB 6same policy, Senate version
Bill progressHistory & official text ↓
Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Proposed

House Bill 30 prohibits the manufacture, distribution, mailing, or provision of abortion-inducing drugs in Texas and enforces these restrictions exclusively through private civil s allowing statutory damages of at least $100,000 per violation, effective September 1, 2025.

Why it matters

Private citizens gain standing to sue anyone who manufactures, distributes, or provides abortion-inducing drugs, and defendants face rules, strict liability limitations, and exclusive appellate jurisdiction in the Fifteenth Court of Appeals.

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

abortion-inducing drug manufacturers

Manufacturers are prohibited from producing or distributing abortion-inducing drugs in the state and face qui tam civil liability and statutory damages.

Directly affected

qui tam relators

Private individuals are granted standing to bring civil enforcement actions and recover statutory damages and attorney fees.

Directly affected

pregnant women

Pregnant women are explicitly exempt from being sued under qui tam actions or attorney general proceedings for obtaining or using abortion-inducing drugs.

Directly affected

internet service providers

Internet service providers, search engines, and cloud service providers are explicitly shielded from liability under the chapter.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Who can enforce the new restrictions on abortion-inducing drugs?
The prohibitions may be enforced exclusively through private qui tam civil actions brought by private persons; state and local government entities and prosecutors are barred from enforcing them.
What are the financial penalties for violating the abortion-inducing drug ban?
If a qui tam relator prevails, the court must award injunctive relief, statutory damages of not less than $100,000 for each violation, and costs and reasonable attorney's fees.
Are pregnant women subject to civil liability under this bill?
No. s and attorney general suits cannot be brought against a woman for using, obtaining, or seeking to obtain abortion-inducing drugs to abort her unborn child.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Follow the record

Votes, people, money & the original source

Where This Stands

This bill did not become law - Died at adjournment · introduced in the House.

Procedural history

1 action
  1. Aug 8, 2025HouseIntroduced
    Filed

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Jeff LeachHouse · District 67RepublicanAuthor

Discoveries

2 patterns noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift99% confidence

Exclusive Private Qui Tam Enforcement Model

The bill shifts enforcement authority away from traditional government prosecutors entirely, relying instead on private citizen qui tam lawsuits with statutory minimum damages.

Fifteenth Court of Appeals
cross reference98% confidence

Centralization of Appellate Review

Exclusive intermediate appellate jurisdiction over all civil actions and appeals under the chapter is funneled directly to the Fifteenth Court of Appeals.

Fifteenth Court of Appeals

Connected Entities

Religious Freedom Restoration Act, Jeff Leach, Fifteenth Court of Appeals and 3 more
otherReligious Freedom Restoration Act“Statute referenced regarding exemptions and liabilities”Map →
PersonJeff Leach“Author and sponsor of House Bill 30”Map →
OrganizationFifteenth Court of Appeals“Granted exclusive intermediate appellate jurisdiction over appeals under the Act”Map →
otherTexas Citizens Participation Act“Exemptions created under the Civil Practice and Remedies Code”Map →
otherSeminole Tribe of Florida v. Florida“Supreme Court precedent regarding sovereign immunity”Map →
otherAlden v. Maine“Supreme Court precedent regarding sovereign immunity”Map →

Sources

Open source document

capitol.texas.gov

Analysis Score

0–100
  • Significance20
    Lowered because this bill did not pass (its text scored 95)
  • Controversy95
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz85
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record